NYSE:STE - STERIS Stock Price, Price Target & More

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

STERIS announced a quarterly dividend on Friday, May 11th. Shareholders of record on Friday, June 8th will be paid a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend is Thursday, June 7th. View STERIS's Dividend History.

STERIS (NYSE:STE) released its quarterly earnings data on Wednesday, May, 9th. The medical equipment provider reported $1.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.22 by $0.02. The medical equipment provider had revenue of $716 million for the quarter, compared to the consensus estimate of $703.37 million. STERIS had a net margin of 11.10% and a return on equity of 11.55%. The firm's revenue was up 5.1% on a year-over-year basis. During the same period last year, the company posted $1.11 EPS. View STERIS's Earnings History.

STERIS is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for STERIS.

STERIS updated its FY19 earnings guidance on Wednesday, May, 9th. The company provided earnings per share guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus estimate of $4.69.

5 Wall Street analysts have issued 12-month target prices for STERIS's shares. Their predictions range from $16.00 to $103.00. On average, they expect STERIS's stock price to reach $80.25 in the next year. View Analyst Ratings for STERIS.

Some companies that are related to STERIS include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), Coloplast (CLPBY), Smith & Nephew (SNN), William Demant (WILYY), Inogen (INGN), Mine Safety Appliances (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX) and Lakeland Industries (LAKE).

Headlines about STE stock have trended somewhat positive on Friday, according to Accern. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. STERIS earned a media sentiment score of 0.04 on Accern's scale. They also gave press coverage about the medical equipment provider an impact score of 46.55 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

STERIS's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.81%), Massachusetts Financial Services Co. MA (2.55%), Westfield Capital Management Co. LP (1.95%), Principal Financial Group Inc. (1.93%), Principal Financial Group Inc. (1.93%) and Fisher Asset Management LLC (1.71%). Company insiders that own STERIS stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for STERIS.

STE stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., Champlain Investment Partners LLC, Envestnet Asset Management Inc., Fisher Asset Management LLC, Westfield Capital Management Co. LP, Daiwa Securities Group Inc. and Public Employees Retirement Association of Colorado. Company insiders that have sold STERIS company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for STERIS.

STE stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Robeco Institutional Asset Management B.V., BlackRock Inc., Massachusetts Financial Services Co. MA, Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN and Chicago Equity Partners LLC. View Insider Buying and Selling for STERIS.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of STE stock can currently be purchased for approximately $104.49.

STERIS has a market capitalization of $8.83 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. STERIS employs 12,000 workers across the globe.

STERIS's mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]